FABRICO TECHNOLOGY, INC.

Austin, TX · Biotech · Private

Cell-free protein synthesis system for scalable production of proteins with non-canonical amino acids incorporated

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Biotech
Headquarters: Austin, TX
Total capital: $8.1M

Federal grants: $2.5M; 5 awards · 2017–2025; Rank in peer group#10 of 13
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $5.6M; 10 awards · Defense; Rank in Biotech#75 of 4373
Granted patents: 3; 7 pending · first 2021; Rank in peer group#6 of 13

Capital timeline

Latest events

Mar 2025Federal grantDefense · Phase II · Dha STTR Phase II Proposal H2-0803, Titled "development Of Antibody Treatment Of Mdr Eskape Pathogen, P. Aeruginosa.", Medical R&d Contract.$1.3M
Mar 2025Federal contractDefense · Dha STTR Phase II Proposal H2-0803, Titled "development Of Antibody Treatment Of Mdr Eskape Pathogen, P. Aeruginosa.", Medical R&d Contract.$1.3M
Mar 2024Federal contractDefense · Dha STTR Ph I Medical Research And Development Purchase Order From Proposal - H23C-001-0029 For "development Of Antibody Treatment Of Mdr Eskape Pathogen, P.aeruginosa$250K
Feb 2024Federal grantDefense · Phase I · Dha STTR Ph I Medical Research And Development Purchase Order From Proposal - H23C-001-0029 For "development Of Antibody Treatment Of Mdr Eskape Pathogen, P.aeruginosa$250K
May 2023Federal contractDefense · Phase II - Base Year$1.1M
May 2023Federal grantDefense · Phase II · Development of Small Molecule Therapeutics Specifically Targeting Members of the Bunyavirales Order$561K
Jan 2023Federal grantDefense · Phase I · Non-canonical genetic code implementation with an optimized, easily scaled cell free lysate system$250K

Show 8 earlier federal awards

Feb 2022Federal contractDefense · FY22 - SBIR - Fabrico Technology Inc.$167K
Feb 2020Federal contractDefense · Medical Research And Development Purchase Order Army STTR Ph I A19B-013-0079 Titled Ratiometric Quantification Of Targeted Methylated Dna Sites Using Mm-lamp-osd&detection Devices$167K
Aug 2018Federal contractDefense · Dha 2017.1 SBIR Phase II Medical R&d Contract For Proposal H2-0310 For Project Titled, "field Portable Coliform Bacteria&e. Coli Rna Biomarker Lamp - Osd System"$1M
Jun 2018Federal contractDefense · Dha SBIR Phase I - H181-004-0015$150K
Aug 2017Federal grantDefense · Phase I · Field portable Coliform Bacteria and Escherichia Coli RNA expression LAMP-OSD detection system$150K
Dec 2013Federal contractDefense · Igf::ot::igf SBIR Phase I Dhp 13.2 H132-012-0072$1.1M
May 2012Federal contractDefense · Research And Development For Solid Waste Remediation System (swrd) For Small Base Camp Contingency$150K
Jan 2012Federal contractDefense · Osd SBIR Phase I Proposal #0112-H12-3068$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 13 peers

Line = median

Biotech · System

Federal grantsBelow median
Granted patents#6 · top 46%
Linked publications#4 · top 31%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 3 granted of 10

Mar 18, 2025GrantedDecellularized And Demineralized Bone Matrices And Methods For Making SameUSPTOUS 12,251,493
Nov 17, 2022PendingSystems And Methods For Measuring Colorimetric ReactionsUSPTOApplication 17771771
Sep 6, 2022GrantedAnalytical Test CartridgeUSPTOUS D,963,193

Show all 10 patent records

Decellularized And Demineralized Bone Matrices And Methods For Making SameMar 18, 2025 · US 12,251,493Granted
Systems And Methods For Measuring Colorimetric ReactionsNov 17, 2022 · Application 17771771Pending
Analytical Test CartridgeSep 6, 2022 · US D,963,193Granted
Decellularized And Demineralized Bone Matrices And Methods For Making SameMar 30, 2021 · US 10,960,108Granted
Decellularized And Demineralized Bone Matrices And Methods For Making SameApplication PCTUS2018037556Pending
Decellularized And Demineralized Bone Matrices And Methods For Making SameApplication 62519277Pending
Systems And Methods For Detecting Target AnalytesApplication PCTUS2011024236Pending
Systems And Methods For Measuring Colorimetric ReactionsApplication PCTUS2020057261Pending
Systems And Methods For Measuring Colorimetric ReactionsApplication 62965951Pending
Systems And Methods For Measuring Colorimetric ReactionsApplication 62931334Pending

Recent research by its founders

Excellent Response to Fam-Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2–Positive Salivary Duct Carcinoma With CNS Metastasis: A Case Report20222 cites
Efficient and unique cobarcoding of second-generation sequencing reads from long DNA molecules enabling cost-effective and accurate sequencing, haplotyping, and de novo assembly2019267 cites
Detecting clinically actionable variants in the 3′ exons of PMS2 via a reflex workflow based on equivalent hybrid capture of the gene and its pseudogene201826 cites

BCN BIOSCIENCES LLCSimilar federal contract value in Biotech · $6.2M in contracts
PAI LIFE SCIENCES INCSimilar federal contract value in Biotech · $5.8M in contracts
60 DEGREES PHARMACEUTICALS, INC.Similar federal contract value in Biotech · $5.8M in contracts
Shuttle Pharmaceuticals, Inc.Similar federal contract value in Biotech · $5.5M in contracts
Inhalon Biopharma, Inc.Similar federal contract value in Biotech · $5.4M in contracts
CELL MICROSYSTEMS INCSimilar federal contract value in Biotech · $5.1M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.